Li Ka-shing's high-street health and beauty chain is very likely to target London and Hong Kong for its $5bn-plus share sale, but only if it can be sure of inclusion in both the Hang Seng and FTSE 100, according to people close to the company.
据知情人士称，李嘉诚旗下的高街健康和美容连锁屈臣氏(AS Watson)非常有可能在伦敦和香港启动其规模逾50亿美元的上市，但只有在它能够确定被纳入恒生指数(Hang Seng)和富时100指数(FTSE 100)的情况下才会上市。
您已阅读18%（359字），剩余82%（1614字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。